United Therapeutics (UTHR) Income from Discontinued Operations (2010 - 2011)
United Therapeutics' (UTHR) quarterly Income from Discontinued Operations came in at $3.8 million in Q3 2011, up 1070.0% year-over-year from $323333.3 in Q3 2010, and up 1684.43% quarter-over-quarter from $212000.0 in Q2 2011.
Powered by 
Analysis
United Therapeutics (UTHR) Income from Discontinued Operations (2010 - 2011) Analysis & Trends
United Therapeutics has disclosed Income from Discontinued Operations across 2 years of filings, most recently posting $3.8 million for Q3 2011.
- In Q3 2011, Income from Discontinued Operations rose 1070.0% year-over-year to $3.8 million; the TTM figure through Dec 2011 stood at $739000.0 (changed N/A YoY), while the FY2011 annual figure was $625000.0, up 111.81% from the prior year.
- Income from Discontinued Operations came in at $3.8 million for Q3 2011 at United Therapeutics, up from $212000.0 in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $3.8 million in Q3 2011 to a low of -$4.6 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | - |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | - |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 8.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2011 | 3.78 Mn |
| Jun 30, 2011 | 212,000.00 |
| Mar 31, 2011 | -3.26 Mn |
| Dec 31, 2010 | -4.63 Mn |
| Sep 30, 2010 | -390,000.00 |
| Jun 30, 2010 | -259,000.00 |